Demographics and risk factor distribution by group
| COVID-19 2020 (group 1) | Non-COVID 2020 (group 2) | 2019 (group 3) | |||
| 1 versus 2 | 2 versus 3 | ||||
| Deaths | |||||
| Week 1 | 8 | 30 | 45 | ||
| Week 2 | 25 | 28 | 24 | ||
| Week 3 | 55 | 22 | 31 | ||
| Week 4 | 65 | 24 | 32 | ||
| Week 5 | 55 | 18 | 31 | ||
| Week 6 | 35 | 14 | 31 | ||
| Weekly average | 41 | 23 | 32 | ||
| Total | 243 | 0.40 | 136 | 0.03 | 194 |
| Sex | |||||
| Male | 67% (162) | <0.001 | 53% (72) | 0.28 | 50% (97) |
| IMD decile | |||||
| 1 | 1% (2) | 0% (0) | 1% (2) | ||
| 2 | 5% (13) | 4% (60 | 3% (6) | ||
| 3 | 10% (24) | 12% (16) | 9% (17) | ||
| 4 | 18% (43) | 12% (16) | 10% (19) | ||
| 5 | 11% (26) | 10% (14) | 10% (20) | ||
| 6 | 15% (37) | 15% (20) | 19% (37) | ||
| 7 | 17% (41) | 11% (15) | 11% (22) | ||
| 8 | 7% (17) | 7% (9) | 9% (17) | ||
| 9 | 8% (19) | 16% (21) | 10% (19) | ||
| 10 | 9% (21) | 0.047 | 13% (18) | 0.62 | 18% (34) |
| 1–5 | 44% (108) | 0.02 | 38% (52) | 0.33 | 33% (64) |
| Ethnicity | |||||
| Non-White | 69% (167) | <0.001 | 58% (79) | 0.04 | 46% (90) |
| Previous comorbidities | |||||
| Diabetes mellitus | 33% (79) | <0.001 | 20% (27) | 0.43 | 16% (32) |
| Hypertension | 53% (129) | 0.02 | 55% (75) | 0.02 | 42% (81) |
| Ischaemic heart disease | 16% (40) | 0.38 | 32% (44) | <0.001 | 13% (26) |
| Comorbidities (#)* | |||||
| 0 | 37% (89) | 33% (45) | 46% (90) | ||
| 1 | 31% (76) | 36% (49) | 38% (73) | ||
| 2 | 26% (62) | 21% (29) | 14% (27) | ||
| 3 | 7% (16) | 0.001 | 10% (13) | 0.002 | 2% (4) |
| Age (median years) | |||||
| White | 81 | 0.93 | 76 | 0.35 | 81 |
| Asian | 71 | 0.95 | 74 | 0.71 | 67 |
| Black | 77 | 0.33 | 77 | 0.37 | 80 |
| Other | 76 | 0.90 | 77 | 0.95 | 77 |
| Not-known/recorded | 76 | 0.54 | 68 | 0.47 | 72 |
| All | 76 | 0.56 | 76 | 0.28 | 78 |
P value comparisons of group 1 or 2 versus group 3.
*Number of comorbidities from diabetes mellitus, hypertension and ischaemic heart disease (range 0–3).
IMD, Index of Multiple Deprivation.